AAAAAA
Results:
1-21
|
Results: 21
Authors:
MASIMIREMBWA CM
DANDARA C
SOMMERS DK
SNYMAN JR
HASLER JA
Citation: Cm. Masimirembwa et al., GENETIC-POLYMORPHISM OF CYTOCHROME P4501A1, MICROSOMAL EPOXIDE HYDROLASE, AND GLUTATHIONE S-TRANSFERASES M1 AND T1 IN ZIMBABWEANS AND VENDAOF SOUTHERN AFRICA, Pharmacogenetics, 8(1), 1998, pp. 83-85
Authors:
NAIK YS
HASLER JA
Citation: Ys. Naik et Ja. Hasler, EFFECT OF SCHISTOSOME INFECTION ON HEPATIC DRUG-METABOLIZING-ENZYMES, South African journal of science, 94(6), 1998, pp. 301-302
Authors:
MAGWERE T
NAIK YS
HASLER JA
Citation: T. Magwere et al., PRIMAQUINE ALTERS ANTIOXIDANT ENZYME PROFILES IN RAT-LIVER AND KIDNEY, Free radical research, 27(2), 1997, pp. 173-179
Authors:
MAGWERE T
NAIK YS
HASLER JA
Citation: T. Magwere et al., EFFECTS OF CHLOROQUINE TREATMENT ON ANTIOXIDANT ENZYMES IN RAT-LIVER AND KIDNEY, Free radical biology & medicine, 22(1-2), 1997, pp. 321-327
Authors:
MASIMIREMBWA CM
HASLER JA
Citation: Cm. Masimirembwa et Ja. Hasler, GENETIC-POLYMORPHISM OF DRUG-METABOLIZING-ENZYMES IN AFRICAN POPULATIONS - IMPLICATIONS FOR THE USE OF NEUROLEPTICS AND ANTIDEPRESSANTS, Brain research bulletin, 44(5), 1997, pp. 561-571
Authors:
MUKANGANYAMA S
MASIMIREMBWA CM
NAIK YS
HASLER JA
Citation: S. Mukanganyama et al., PHENOTYPING OF THE GLUTATHIONE-S-TRANSFERASE-M1 POLYMORPHISM IN ZIMBABWEANS AND THE EFFECTS OF CHLOROQUINE ON BLOOD GLUTATHIONE-S-TRANSFERASE-M1 AND GLUTATHIONE-S-TRANSFERASE-A, Clinica chimica acta, 265(2), 1997, pp. 145-155
Authors:
MASIMIREMBWA CM
GUSTAFSSON LL
DAHL ML
ABDI YA
HASLER JA
Citation: Cm. Masimirembwa et al., LACK OF EFFECT OF CHLOROQUINE ON THE DEBRISOQUINE (CYP2D6) AND S-MEPHENYTOIN (CYP2C19) HYDROXYLATION PHENOTYPES, British journal of clinical pharmacology, 41(4), 1996, pp. 344-346
Authors:
TODD CH
ALLAIN T
GOMO ZAR
HASLER JA
NDIWENI M
OKEN E
Citation: Ch. Todd et al., INCREASE IN THYROTOXICOSIS ASSOCIATED WITH IODINE SUPPLEMENTS IN ZIMBABWE, Lancet, 346(8989), 1995, pp. 1563-1564
Authors:
MASIMIREMBWA CM
HASLER JA
JOHANSSON I
Citation: Cm. Masimirembwa et al., INHIBITORY EFFECTS OF ANTIPARASITIC DRUGS ON CYTOCHROME-P450 2D6, European Journal of Clinical Pharmacology, 48(1), 1995, pp. 35-38
Authors:
MASIMIREMBWA C
BERTILSSON L
JOHANSSON I
HASLER JA
INGELMANSUNDBERG M
Citation: C. Masimirembwa et al., PHENOTYPING AND GENOTYPING OF S-MEPHENYTOIN HYDROXYLASE (CYTOCHROME-P450 2C19) IN A SHONA POPULATION OF ZIMBABWE, Clinical pharmacology and therapeutics, 57(6), 1995, pp. 656-661
Authors:
MASIMIREMBWA CM
BEKE M
HASLER JA
TANG BK
KALOW W
Citation: Cm. Masimirembwa et al., LOW CYP1A2 ACTIVITY IN RURAL SHONA CHILDREN OF ZIMBABWE, Clinical pharmacology and therapeutics, 57(1), 1995, pp. 25-31
Authors:
MASIMIREMBWA CM
NAIK YS
HASLER JA
Citation: Cm. Masimirembwa et al., THE EFFECT OF CHLOROQUINE ON THE PHARMACOKINETICS AND METABOLISM OF PRAZIQUANTEL IN RATS AND IN HUMANS, Biopharmaceutics & drug disposition, 15(1), 1994, pp. 33-43
THE EFFECT OF EXPERIMENTAL SCHISTOSOMA-MATTHEEI INFECTION ON HEPATIC DRUG-METABOLISM IN BALB C MICE/
Authors:
NAIK YS
HASLER JA
Citation: Ys. Naik et Ja. Hasler, THE EFFECT OF EXPERIMENTAL SCHISTOSOMA-MATTHEEI INFECTION ON HEPATIC DRUG-METABOLISM IN BALB C MICE/, Journal of veterinary pharmacology and therapeutics, 17(6), 1994, pp. 477-479
Authors:
HASLER JA
DUBE N
NYATHI CB
FUHRMANN H
SALLMANN HP
Citation: Ja. Hasler et al., THE INFLUENCE OF DIETARY-FAT ON HEPATIC BIOACTIVATION OF AFLATOXIN B-1 IN RATS, Research communications in chemical pathology and pharmacology, 83(3), 1994, pp. 279-287
Authors:
HASLER JA
HARLOW GR
SZKLARZ GD
JOHN GH
KEDZIE KM
BURNETT VL
HE YA
KAMINSKY LS
HALPERT JR
Citation: Ja. Hasler et al., SITE-DIRECTED MUTAGENESIS OF PUTATIVE SUBSTRATE RECOGNITION SITES IN CYTOCHROME-P450-2B11 - IMPORTANCE OF AMINO-ACID RESIDUE-114, RESIDUE-290, AND RESIDUE-363 FOR SUBSTRATE-SPECIFICITY, Molecular pharmacology, 46(2), 1994, pp. 338-345
CHARACTERIZATION OF PRAZIQUANTEL METABOLISM BY RAT-LIVER MICROSOMES USING CYTOCHROME-P450 INHIBITORS
Authors:
MASIMIREMBWA CM
HASLER JA
Citation: Cm. Masimirembwa et Ja. Hasler, CHARACTERIZATION OF PRAZIQUANTEL METABOLISM BY RAT-LIVER MICROSOMES USING CYTOCHROME-P450 INHIBITORS, Biochemical pharmacology, 48(9), 1994, pp. 1779-1783
Authors:
JOHN GH
HASLER JA
HE YA
HALPERT JR
Citation: Gh. John et al., ESCHERICHIA-COLI EXPRESSION AND CHARACTERIZATION OF CYTOCHROMES P450 2B11, 2B1, AND 2B5, Archives of biochemistry and biophysics, 314(2), 1994, pp. 367-375
Authors:
JOHN GH
HASLER JA
HE YA
HALPERT JR
Citation: Gh. John et al., ESCHERICHIA-COLI EXPRESSION AND CHARACTERIZATION OF CYTOCHROMES P450 2B11, 2B1, AND 2B5, Archives of biochemistry and biophysics, 314(2), 1994, pp. 367-375
Authors:
MASIMIREMBWA CM
JOHANSSON I
HASLER JA
INGELMANSUNDBERG M
Citation: Cm. Masimirembwa et al., GENETIC-POLYMORPHISM OF CYTOCHROME-P450 CYP2D6 IN ZIMBABWEAN POPULATION, Pharmacogenetics, 3(6), 1993, pp. 275-280
Authors:
MASIMIREMBWA CM
NAIK YS
HASLER JA
Citation: Cm. Masimirembwa et al., EFFECTS OF PHENOBARBITAL AND 3-METHYLCHOLANTHRENE PRETREATMENT ON THEPHARMACOKINETICS OF PRAZIQUANTEL IN RATS, European journal of drug metabolism and pharmacokinetics, 18(3), 1993, pp. 261-264
Authors:
NYATHI CB
DUBE N
HASLER JA
OBWOLO MJ
FUHRMANN H
SALLMANN HP
Citation: Cb. Nyathi et al., THE EFFECT OF DIET ON AFLATOXIN-B(1) BINDING TO HEPATIC MACROMOLECULES IN RATS, Research communications in chemical pathology and pharmacology, 82(2), 1993, pp. 199-207
Risultati:
1-21
|